Medulloblastoma (MB) is among the most malignant of pediatric brain tumors, having an average 5-year survival rate of only 50%. MB is believed to arise mostly from the undifferentiated neural stem/progenitor cells (CPCs) of the external granule layer cells of the cerebellum. Although developmentally important signaling pathways such as Wnt and Hedgehog are known to be activated in some MBs, the mechanism of tumorigenesis remains unknown for the majority of human MBs. Thus, one challenge for studies of MB is to understand the mechanisms that regulate most MBs. Our previous studies with human medulloblastoma tumor samples, a tissue culture system of CPCs, and an orthotopic intracranial mouse model system suggested that the transcription factor REST is a critical player in a major percentage of human MBs. On the basis of our current findings, we propose to test the hypothesis that the mechanism of REST-mediated MB tumorigenesis involves blocking the neuronal differentiation of CPCs by arresting them in a self-renewal mode (maintenance of """"""""stemness"""""""") and also by repressing the transcription of other target genes relevant in MB tumorigenesis. We further propose that the abnormal overexpression of REST seen in many MBs is due in part to mutations in the REST gene promoter. Thus, the proposed studies will yield critical information relevant to our long- term goals of studying the genesis of REST-mediated MB tumorigenesis and producing mechanism-based animal models that can be used both to identify new, physiologically relevant targets for therapy and to test existing and new drugs for MB. The experiments proposed here are in accordance with the recommendations of the NCI Brain Tumor Progress Review Group. Furthermore, because our proposed project involves neural stem/progenitor cells and medulloblastoma, it may be suitable for Program Announcement PA- 05-086 (""""""""Stem Cells and Cancer"""""""").
Medulloblastoma (MB) is among the most malignant of pediatric brain tumors. This project in the past has lead to the discovery of a novel regulator of human MB (REST) and will now continue to decipher the role of REST in medulloblastoma mechanism and possible therapy.
|Marisetty, Anantha L; Singh, Sanjay K; Nguyen, Tran N et al. (2017) REST represses miR-124 and miR-203 to regulate distinct oncogenic properties of glioblastoma stem cells. Neuro Oncol 19:514-523|
|Singh, Sanjay K; Marisetty, Anantha; Sathyan, Pratheesh et al. (2015) REST-miR-21-SOX2 axis maintains pluripotency in E14Tg2a.4 embryonic stem cells. Stem Cell Res 15:305-11|
|Sathyan, Pratheesh; Zinn, Pascal O; Marisetty, Anantha L et al. (2015) Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci 35:15097-112|
|Kamal, Mohamed M; Sathyan, Pratheesh; Singh, Sanjay K et al. (2012) REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells 30:405-14|
|Singh, Sanjay K; Veo, Bethany L; Kagalwala, Mohamedi N et al. (2012) Dynamic status of REST in the mouse ESC pluripotency network. PLoS One 7:e43659|
|Gopalakrishnan, Vidya; Bie, Bihua; Sinnappah-Kang, Neeta D et al. (2010) Myoblast-derived neuronal cells form glutamatergic neurons in the mouse cerebellum. Stem Cells 28:1839-47|
|Singh, Sanjay K; Kagalwala, Mohamedi N; Parker-Thornburg, Jan et al. (2008) REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453:223-7|
|Kagalwala, M N; Singh, S K; Majumder, S (2008) Stemness is only a state of the cell. Cold Spring Harb Symp Quant Biol 73:227-34|
|Majumder, Sadhan (2006) REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle 5:1929-35|
|Su, Xiaohua; Kameoka, Sei; Lentz, Susan et al. (2004) Activation of REST/NRSF target genes in neural stem cells is sufficient to cause neuronal differentiation. Mol Cell Biol 24:8018-25|